Neonatal Cholestasis
Neonatal Cholestasis
Neonatal Cholestasis
Etiology:
The cause of neonatal cholestasis can be genetic, metabolic, infectious or undefined causing mechanical obstruction of bile flow e.g. Biliary atresia or bile acid secretion or functional impairment of
hepatic excretory e.g. Congenital infections.
The common causes of Neonatal cholestasis include:
1.
2.
3.
4.
Investigations
Lets take a short overview of the investigations helpful in diagnosis. Investigations of preference depend
on the clinical presentation of the patient. Usual investigations done are :
Test
Implication
Confirms cholestasis
Liver function tests including GGTP High GGTP with high alkaline phosphatase suggests
obstruction
and alkaline phosphatase
Low GGTP with high alkaline phosphatase suggests PFIC
Normal GGTP and normal alkaline phosphatase may suggest
non-obstructive causes
Indicates bile flow into intestine. Clay coloured stools
Assessment of stool colour
suggests obstruction
Urine/serum bile acid measurement
Confirms cholestasis
USG
HIDA scan
Specific investigations:
Thyroxine and TSH
Hypothyroidism, panhypopituitarism
Sweat chloride
Cystic fibrosis
Urine/plasma amino
reducing substance
TORCH titres
2 D Echo
Hearing
and
examination
Liver biopsy
inconclusive.
Non-obstructive causes
Full term
Preterm/Full term
AGA/LBW
No ANC/PNC complications
Yellow stools
Growing well
Failure to thrive
Hepatosplenomegaly
* Babies with NCS due to infections of Herpes, Toxoplasmosis and rarely CMV may be sick, look for their
extra hepatic manifestations. Stop milk feeds till galactosemia is ruled out. In febrile babies, look for
malarial parasite, sepsis and UTI.
** This is to look for galactose in urine while on milk feeds. If reducing substances are positive, check
urine samples with glucose stick. If negative, most likely reducing substances in urine are due to
galactose. Treat as galactosemia. GALI-PUT should be done to confirm the diagnosis.
However there may be instances where liver biopsy may be inconclusive due to improper reporting or
due to evolving disease and in such instances either serial liver biopsies or urgent cholangiogram may be
needed to find out the cause. (3). Thus based on our clinical experience of over 200 patients, where the
only clinical marker for biliary atresia was clay stools (4) we have modified our approach to neonatal
cholestasis as follows:
* Liver biopsy and Intraoperative cholangiogram are done depending on the reports of the tests in
patients with yellow stools.
Conclusion: Neonatal cholestasis syndrome is a hepatobiliary emergency and timely referral is essential
to avoid irreversible liver damage.
References:
1. Sanghai Saket, Shah Ira, Bhatnagar Sushmita. Incidence and Prognostic factors associated with
Biliary Atresia in Western India. Annals Hepatol. 2009; 8: 120-122.
2. Pediatric Gastroenterology Subspecialty Chapter of Indian Academy of Pediatrics. Consensus
Report on Neonatal Cholestasis Syndrome. Indian Pediatrics 2000;37: 845-851
3. Sweta Mohanty, Ira Shah, Sushmita Bhatnagar. Evolving Biliary Atresia With Cytomegalovirus.
Accepted For Publication In Indian Pediatrics. 2010
4. Ira Shah, Sushmita Bhatnagar. Clinical and Laboratory Markers predictive of Biliary Atresia.
Mahapedicon 2008, Mahabaleshwar, 14-15th November 2008.